Deepe G S
Division of Infectious Diseases, University of Cincinnati College of Medicine, Ohio 45267-0560, USA.
Clin Microbiol Rev. 1997 Oct;10(4):585-96. doi: 10.1128/CMR.10.4.585.
In an era that emphasizes the term "cost-effective," vaccines are the ideal solution to preventing disease at a relatively low cost to society. Much of the previous emphasis has been on childhood scourges such as measles, mumps, rubella, poliomyelitis, and Haemophilus influenzae type b. The concept of vaccines for fungal diseases has had less impact because of the perceived limited problem. However, fungal diseases have become increasingly appreciated as serious medical problems that require recognition and aggressive management. The escalation in the incidence and prevalence of infection has prompted a renewed interest in vaccine development. Herein, I discuss the most recent developments in the search for vaccines to combat fungal infections. Investigators have discovered several inert substances from various fungi that can mediate protection in animal models. The next challenge will be to find the suitable mode of delivery for these immunogens.
在一个强调“性价比”的时代,疫苗是以相对较低的社会成本预防疾病的理想解决方案。此前,人们大多将重点放在儿童易患的疾病上,如麻疹、腮腺炎、风疹、脊髓灰质炎和b型流感嗜血杆菌。由于认为真菌疾病问题有限,针对真菌疾病的疫苗概念影响较小。然而,真菌疾病已越来越被视为需要识别和积极治疗的严重医学问题。感染发病率和患病率的上升促使人们重新对疫苗研发产生兴趣。在此,我将讨论在寻找抗真菌感染疫苗方面的最新进展。研究人员已经从各种真菌中发现了几种惰性物质,它们可以在动物模型中起到保护作用。下一个挑战将是为这些免疫原找到合适的递送方式。